Reviewing Covalon Technologies (COV) & Its Rivals

Covalon Technologies (NYSE: COV) is one of 89 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its competitors? We will compare Covalon Technologies to related businesses based on the strength of its profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Institutional & Insider Ownership

67.6% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 11.5% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Covalon Technologies and its competitors revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Covalon Technologies N/A N/A 27.43
Covalon Technologies Competitors $1.06 billion $127.98 million 193.38

Covalon Technologies’ competitors have higher revenue and earnings than Covalon Technologies. Covalon Technologies is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent ratings for Covalon Technologies and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Covalon Technologies 0 0 0 0 N/A
Covalon Technologies Competitors 207 1276 2772 100 2.63

As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 5.71%. Given Covalon Technologies’ competitors higher probable upside, analysts clearly believe Covalon Technologies has less favorable growth aspects than its competitors.

Profitability

This table compares Covalon Technologies and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Covalon Technologies 19.02% 20.06% 9.92%
Covalon Technologies Competitors -128.97% -39.17% -10.29%

Risk & Volatility

Covalon Technologies has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Covalon Technologies’ competitors have a beta of 1.11, meaning that their average share price is 11% more volatile than the S&P 500.

Summary

Covalon Technologies competitors beat Covalon Technologies on 5 of the 8 factors compared.

About Covalon Technologies

Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company’s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company’s segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company’s products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Receive News & Ratings for Covalon Technologies Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies Ltd and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply